Gene · 442918
Papers2,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integration Analysis of circRNA-miRNA-mRNA and Identification of Critical Networks in Valgus-Varus Deformity (Gallus gallus). | Genes (Basel) | 2023 | 36980895 | PubTator, text mining | PubMed |
| Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer. | Cancers (Basel) | 2023 | 36980520 | PubTator, text mining | PubMed |
| The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review. | Front Pharmacol | 2023 | 36969852 | PubTator, text mining | PubMed |
| Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs. | Front Endocrinol (Lausanne) | 2023 | 36950696 | PubTator, text mining | PubMed |
| A strategy for the treatment of gastrointestinal cancer: Targeting tumor senescent cells. | Front Mol Biosci | 2023 | 36950520 | PubTator, text mining | PubMed |
| MicroRNAs in cancer metastasis: biological and therapeutic implications. | Expert Rev Mol Med | 2023 | 36927814 | PubTator, text mining | PubMed |
| Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 36900258 | PubTator, text mining | PubMed |
| Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave. | Cancers (Basel) | 2023 | 36900200 | PubTator, text mining | PubMed |
| Circular RNAs: implications of signaling pathways and bioinformatics in human cancer. | Cancer Biol Med | 2023 | 36861443 | PubTator, text mining | PubMed |
| miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. | Viruses | 2023 | 36851643 | PubTator, text mining | PubMed |
| Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer. | Molecules | 2023 | 36838790 | PubTator, text mining | PubMed |
| Is the Non-Coding RNA miR-195 a Biodynamic Marker in the Pathogenesis of Head and Neck Squamous Cell Carcinoma? A Prognostic Meta-Analysis. | J Pers Med | 2023 | 36836509 | PubTator, text mining | PubMed |
| Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer. | Int J Mol Sci | 2023 | 36835649 | PubTator, text mining | PubMed |
| SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis. | Int J Mol Sci | 2023 | 36835620 | PubTator, text mining | PubMed |
| An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence. | Int J Mol Sci | 2023 | 36835336 | PubTator, text mining | PubMed |
| Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells. | Int J Mol Sci | 2023 | 36835116 | PubTator, text mining | PubMed |
| Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products. | Int J Mol Sci | 2023 | 36835100 | PubTator, text mining | PubMed |
| Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy. | Int J Mol Sci | 2023 | 36834660 | PubTator, text mining | PubMed |
| Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development. | Cells | 2023 | 36831302 | PubTator, text mining | PubMed |
| Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis. | Cells | 2023 | 36831192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442918/papers?page=9